First Manhattan’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,000
| Closed | – | – | 1704 |
|
|
2022
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1555 |
|
|
2022
Q1 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1598 |
|
|
2021
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1577 |
|
|
2021
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 1591 |
|
|
2021
Q2 | $0 | Sell |
1,000
-3,000
| -75% | – | ﹤0.01% | 1553 |
|
|
2021
Q1 | $0 | Hold |
4,000
| – | – | ﹤0.01% | 1471 |
|
|
2020
Q4 | $1K | Hold |
4,000
| – | – | ﹤0.01% | 1294 |
|
|
2020
Q3 | $1K | Sell |
4,000
-1,000
| -20% | -$250 | ﹤0.01% | 1285 |
|
|
2020
Q2 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1309 |
|
|
2020
Q1 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1288 |
|
|
2019
Q4 | $2K | Buy |
+5,000
| New | +$2K | ﹤0.01% | 1241 |
|